Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-16

Clinical Trial Update: A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) [Phase 3]

View source ↗

Summary

This update reports the completion of the Phase 3 AWARD-3 trial in adults with type 2 diabetes and that results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRULICITY (DULAGLUTIDE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-01-16